C-peptide and Retinal Microangiopathy in Diabetes
Author Information
Author(s): Subrata Chakrabarti, Zia Ali Khan, Mark Cukiernik, Weixian Zhang, Anders A. F. Sima
Primary Institution: University of Western Ontario
Hypothesis
Does C-peptide treatment affect ECM protein production and capillary basement membrane thickening in the retina of diabetic rats?
Conclusion
C-peptide treatment prevents diabetes-induced oncofetal fibronectin expression but does not prevent capillary basement membrane thickening.
Supporting Evidence
- C-peptide treatment normalized oncofetal fibronectin levels in diabetic rats.
- Diabetes caused significant increases in mRNA expression of ET-1 and TGF-.
- C-peptide treatment was ineffective in preventing diabetes-induced increases in capillary basement membrane thickness.
Takeaway
C-peptide can help reduce a specific protein linked to eye problems in diabetes, but it doesn't stop the thickening of blood vessel walls in the eye.
Methodology
The study involved treating diabetic BB/Wor rats with C-peptide for 8 months and analyzing retinal tissues for gene expression and histological changes.
Limitations
The study does not explore other potential factors involved in capillary basement membrane thickening.
Participant Demographics
Diabetic BB/Wor rats and age-matched nondiabetic control rats.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website